March 20, 2026

FDA Clears Setmelanotide for Hypothalamic Obesity

First and only FDA-approved therapy showed an 18.4% placebo-adjusted BMI reduction at 52 weeks

Conexiant

March 18, 2026

AAP, NASPGHAN Issue Guidance on Faltering Weight in Children

New recommendations standardize diagnosis and aim to reduce unnecessary interventions in early childhood growth concerns.

Conexiant

March 17, 2026

Teen Conflict and the Body’s Clock

Parent and peer relationship patterns across adolescence are examined alongside biomarkers of aging.

Conexiant

March 04, 2026

AI's Expanding Role in Diabetes Care

Machine learning models applied to inpatient electronic health record data have predicted insulin needs more accurately than traditional guidelines.

Conexiant

March 04, 2026

AI Carb Estimates From ChatGPT a Glycemic Risk?

"The findings of this study indicate that individuals living with T1D should use ChatGPT-4o to estimate carbohydrates with caution,"

Conexiant

March 02, 2026

FDA Okays Weekly Option in Achondroplasia

Navepegritide is described as the first therapy to deliver continuous C-type natriuretic peptide exposure over a weekly dosing interval in eligible pediatric patients.

Conexiant

February 26, 2026

AHA Issues Pediatric Hypertriglyceridemia Statement

The scientific statement defines pancreatitis and atherosclerotic cardiovascular disease risk thresholds and outlines causes and management in youths.

Conexiant

February 25, 2026

AI and Diabetes: Promise and Precaution

The growing ability of AI systems “to influence human biology and lifespan might have implications we are not yet able to grasp."

Conexiant

January 14, 2026

ADA explores opportunities to educate dentists on Type 1 diabetes

In response to a House of Delegates resolution, the ADA is exploring ways to educate dentists on Type 1 diabetes and oral health.

ADA News

January 27, 2026

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.

Conexiant